+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Germany Metered Dose Inhaler Market 2019-2025

  • ID: 4987983
  • Report
  • January 2020
  • Region: Germany
  • Orion Market Research Private Limited
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • 3M Co.
  • Adherium Ltd.
  • Bespak
  • Koninklijke Philips N.V.
  • Omron Healthcare Inc.
  • ResMed Corp.
  • MORE
Germany Metered Dose Inhaler Market Size, Share & Trends Analysis Report by Type (Preventive Inhaler, Reliever Inhaler, and Long-Acting Bronchodilators Inhaler), by Application (Asthma and Chronic Obstructive Pulmonary Disease (COPD)), by End-User (Homecare and Hospitals and Clinics) and Forecast 2019-2025.

Germany metered dose inhaler market is anticipated to grow at a substantial rate of around 4.0% during the forecast period. Germany is one of the key economies of the European region in terms of revenue generation and future opportunities for the metered dose inhaler market. Major factors that augment the growth of the metered dose inhaler market in the country include the significant prevalence of respiratory diseases such as asthma and COPD coupled with increasing geriatric population and growing focus towards the development of therapeutics to treat respiratory diseases.

According to the International Monetary Fund, in 2017, the population of the country was about 80 million and the share of the geriatric population is around 21%. Major companies working in the field of respiratory drug and device industry. Ingelheim based Boehringer Ingelheim International GmbH collaborated with Weill Cornell Medicine in February 2017. The collaboration aims to find new treatment approaches for chronic pulmonary diseases. The three-year collaboration aimed to develop novel treatments that could stop and decrease the progression of COPD.

Germany metered dose inhaler market is segmented based on type, application, and end-user. Based on the type, preventive, reliever, and long-acting bronchodilators inhalers are analyzed. The preventive inhaler segment led the global metered dose inhaler market in 2018. Preventive inhalers are most widely used in the treatment of asthma in children and adults. These inhalers do not entail side effects for long-term use, and exceptionally decreases the possibility of an asthma exacerbation. The preventive inhalers further reduce the airways swelling and hence, are recommended for regular use by the physician. Some of the preventive inhalers available in the market include Budesonide and Fluticasone. Moreover, based on the application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.

Furthermore, the market is characterized by the presence of several manufacturers that are developing and providing metered dose inhalers to cater to a wide range of customers within Germany and across the globe. The major players of the Germany Metered Dose Inhaler market include Boehringer Ingelheim International GmbH, AstraZeneca PLC, GlaxoSmithKline PLC, Novartis AG, Teva Pharmaceuticals Industries Ltd., Koninklijke Philips N.V., and many others. These players adopt various strategies to capitalize on market growth opportunities. Mergers and acquisitions, product launch, geographical expansion, partnerships, and collaborations are the majorly adopted strategies by the market players.

Research Methodology

The market study of the Germany metered dose inhaler market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors.

Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog
The report is intended for metered dose inhaler manufacturers, contract research organizations (CROs), healthcare sector, market research firms, and government organizations, for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. Germany Metered Dose Inhaler Market Research and Analysis by Type
2. Germany Metered Dose Inhaler Market Research and Analysis by Application
3. Germany Metered Dose Inhaler Market Research and Analysis by End-User

The Report Covers
  • Comprehensive research methodology of the Germany metered dose inhaler market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Germany metered dose inhaler market.
  • Insights about market determinants which are stimulating the Germany metered dose inhaler market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 3M Co.
  • Adherium Ltd.
  • Bespak
  • Koninklijke Philips N.V.
  • Omron Healthcare Inc.
  • ResMed Corp.
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. Germany Metered Dose Inhaler Market by Type
5.1.1. Preventive Inhaler
5.1.2. Reliever Inhaler
5.1.3. Long Acting Bronchodilators Inhaler
5.2. Germany Metered Dose Inhaler Market by Application
5.2.1. Asthma
5.2.2. Chronic Obstructive Pulmonary Disease (COPD)
5.3. Germany Metered Dose Inhaler Market by End-User
5.3.1. Homecare
5.3.2. Hospitals and Clinics

6. Company Profiles
6.1. 3M Co.
6.2. Acorda Therapeutics, Inc.
6.3. Adamis Pharmaceuticals Corp.
6.4. Adherium Ltd.
6.5. AstraZeneca PLC
6.6. Bespak
6.7. Boehringer Ingelheim International GmbH
6.8. Chiesi Farmaceutici S.P.A.
6.9. GlaxoSmithKline PLC
6.10. H&T Presspart Manufacturing Ltd.
6.11. Koninklijke Philips N.V.
6.12. Novartis AG
6.13. Omron Healthcare Inc.
6.14. ResMed Corp.
6.15. Pulmatrix Inc.
6.16. Savara, Inc.
6.17. Teicos Pharma Ltd.
6.18. Teva Pharmaceuticals Industries Ltd.
6.19. Vitalograph Ltd.
Note: Product cover images may vary from those shown
3 of 3
  • 3M Co.
  • Acorda Therapeutics, Inc.
  • Adamis Pharmaceuticals Corp.
  • Adherium Ltd.
  • AstraZeneca PLC
  • Bespak
  • Boehringer Ingelheim International GmbH
  • Chiesi Farmaceutici S.P.A.
  • GlaxoSmithKline PLC
  • H&T Presspart Manufacturing Ltd.
  • Koninklijke Philips N.V.
  • Novartis AG
  • Omron Healthcare Inc.
  • ResMed Corp.
  • Pulmatrix Inc.
  • Savara, Inc.
  • Teicos Pharma Ltd.
  • Teva Pharmaceuticals Industries Ltd.
  • Vitalograph Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll